Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 26

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Amyloid‐beta1–42 induced glutamatergic receptor and transporter expression changes in the mouse hippocampus

Yeung, Jason H.Y., Calvo‐Flores Guzmán, Beatriz, Palpagama, Thulani H., Ethiraj, Jayarjun, Zhai, Ying, Tate, Warren P., Peppercorn, Katie, Waldvogel, Henry J., Faull, Richard L.M., Kwakowsky, Andrea · 2020 · Journal of Neurochemistry

Abstract

Alzheimer's disease (AD) is the leading type of dementia worldwide. With an increasing burden of an aging population coupled with the lack of any foreseeable cure, AD warrants the current intense research effort on the toxic effects of an increased concentration of beta‐amyloid (Aβ) in the brain. Glutamate is the main excitatory brain neurotransmitter and it plays an essential role in the function and health of neurons and neuronal excitability. While previous studies have shown alterations in expression of glutamatergic signaling components in AD, the underlying mechanisms of these changes are not well understood. This is the first comprehensive anatomical study to characterize the subregion‐ and cell layer‐specific long‐term effect of Aβ 1–42 on the expression of specific glutamate receptors and transporters in the mouse hippocampus, using immunohistochemistry with confocal microscopy. Outcomes are examined 30 days after Aβ 1–42 stereotactic injection in aged male C57BL/6 mice. We report significant decreases in density of the glutamate receptor subunit GluA1 and the vesicular glutamate transporter (VGluT) 1 in the conus ammonis 1 region of the hippocampus in the Aβ 1–42 injected mice compared with artificial cerebrospinal fluid injected and naïve controls, notably in the stratum oriens and stratum radiatum. GluA1 subunit density also decreased within the dentate gyrus dorsal stratum moleculare in Aβ 1–42 injected mice compared with artificial cerebrospinal fluid injected controls. These changes are consistent with findings previously reported in the human AD hippocampus. By contrast, glutamate receptor subunits GluA2, GluN1, GluN2A, and VGluT2 showed no changes in expression. These findings indicate that Aβ 1–42 induces brain region and layer specific expression changes of the glutamatergic receptors and transporters, suggesting complex and spatial vulnerability of this pathway during development of AD neuropathology. image Read the Editorial Highlight for this article on page 7. Cover Image for this issue: https://doi.org/10.1111/jnc.14763.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jnc.15099

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Research works printed but not linked: 78

  1. 10.1016/S0165-0173(98)00050-2 · DOI · Paper page
  2. 10.1007/BF02815205 · DOI
  3. 10.1016/0006-8993(94)91732-9 · DOI
  4. 10.1523/JNEUROSCI.3013-14.2015 · DOI
  5. 10.1093/cercor/bhp133 · DOI
  6. 10.1111/nmo.12233 · DOI
  7. 10.1523/JNEUROSCI.3639-07.2008 · DOI · Paper page
  8. 10.1016/S0022-510X(02)00087-4 · DOI
  9. 10.2165/00023210-200317090-00004 · DOI · Paper page
  10. 10.3390/molecules25030693 · DOI
  11. 10.1016/j.expneurol.2003.12.010 · DOI
  12. 10.1006/nbdi.2000.0330 · DOI
  13. 10.1016/S0959-4388(00)00215-4 · DOI · Paper page
  14. 10.1111/j.1476-5381.2012.02057.x · DOI · Paper page
  15. Dingledine R., 1999, The glutamate receptor ion channels, Pharmacological Reviews, 51, 7
  16. 10.1186/s13578-020-00393-4 · DOI
  17. 10.1016/j.ceca.2011.11.008 · DOI · Paper page
  18. 10.1111/j.1471-4159.1984.tb09689.x · DOI · Paper page
  19. 10.1126/science.1097468 · DOI · Paper page
  20. 10.1016/j.neuroscience.2017.03.041 · DOI
  21. 10.1016/j.mcn.2011.05.001 · DOI · Paper page
  22. 10.1016/0278-5846(88)90102-9 · DOI · Paper page
  23. 10.1002/hipo.10195 · DOI
  24. 10.1002/hipo.20006 · DOI
  25. 10.1046/j.1460-9568.2000.00164.x · DOI · Paper page
  26. 10.3389/fnana.2015.00130 · DOI
  27. 10.1523/JNEUROSCI.21-22-j0001.2001 · DOI · Paper page
  28. 10.1016/S0169-328X(00)00194-7 · DOI · Paper page
  29. 10.1126/science.1709304 · DOI · Paper page
  30. 10.1016/j.neuron.2006.10.035 · DOI · Paper page
  31. 10.1371/journal.pone.0140868 · DOI
  32. 10.1016/j.neuroscience.2016.09.027 · DOI
  33. 10.1110/ps.8.8.1668 · DOI · Paper page
  34. 10.1016/j.neurobiolaging.2007.04.010 · DOI · Paper page
  35. 10.1016/j.brainres.2005.06.081 · DOI
  36. 10.1523/ENEURO.0383-17.2018 · DOI
  37. 10.1111/j.1471-4159.2006.03935.x · DOI · Paper page
  38. 10.1016/j.neuroscience.2016.02.048 · DOI
  39. 10.1111/jnc.14325 · DOI
  40. 10.1038/srep21101 · DOI
  41. 10.1124/jpet.103.053694 · DOI
  42. 10.1523/JNEUROSCI.0849-05.2005 · DOI · Paper page
  43. 10.1210/en.2002-220908 · DOI
  44. 10.1016/0166-2236(87)90025-7 · DOI · Paper page
  45. 10.1016/j.neuron.2012.03.021 · DOI · Paper page
  46. 10.1016/j.neuroscience.2008.08.022 · DOI · Paper page
  47. 10.1212/WNL.34.7.939 · DOI · Paper page
  48. 10.1111/j.1471-4159.2007.05147.x · DOI · Paper page
  49. 10.1046/j.1460-9568.2003.02698.x · DOI · Paper page
  50. 10.1523/JNEUROSCI.2556-06.2006 · DOI · Paper page
  51. 10.1038/ncomms15800 · DOI
  52. 10.1016/j.hal.2018.08.008 · DOI
  53. 10.1101/lm.1398709 · DOI
  54. 10.1002/jnr.24214 · DOI
  55. 10.1016/j.expneurol.2007.10.008 · DOI · Paper page
  56. 10.1016/0028-3908(94)00129-G · DOI · Paper page
  57. 10.1002/hipo.22607 · DOI
  58. 10.1523/JNEUROSCI.0360-18.2018 · DOI
  59. 10.1016/j.nbd.2011.08.027 · DOI
  60. 10.3389/fncel.2019.00111 · DOI
  61. 10.1073/pnas.91.23.11158 · DOI
  62. 10.1016/0166-2236(96)10043-6 · DOI · Paper page
  63. 10.1016/S0022-510X(00)00467-6 · DOI
  64. 10.3390/nu9070686 · DOI
  65. 10.1073/pnas.0608807104 · DOI
  66. 10.1016/S0306-4522(97)00023-7 · DOI
  67. 10.1523/JNEUROSCI.22-01-00142.2002 · DOI · Paper page
  68. 10.1016/j.neuron.2017.09.024 · DOI · Paper page
  69. 10.1016/S0197-4580(99)00035-4 · DOI · Paper page
  70. 10.3389/fnmol.2011.00042 · DOI
  71. 10.1073/pnas.0401764101 · DOI · Paper page
  72. 10.3389/fncel.2018.00337 · DOI
  73. 10.1016/0006-8993(95)00178-S · DOI · Paper page
  74. 10.3389/fnins.2019.01427 · DOI
  75. 10.1016/j.expneurol.2008.01.011 · DOI
  76. Zhang B., 2018, Postsynaptic GluR2 involved in amelioration of Aβ‐induced memory dysfunction by Kaixin‐San through rescuing hippocampal LTP in mice, Rejuv Res
  77. 10.1155/2017/8197085 · DOI
  78. 10.1038/srep42788 · DOI

Cited by

Metadata

Authors
Yeung, J. H. Y., Calvo‐Flores Guzmán, B., Palpagama, T. H., Ethiraj, J., Zhai, Y., Tate, W. P., Peppercorn, K., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A.
Affiliations
  • Centre for Brain Research Department of Anatomy and Medical Imaging Faculty of Medical and Health Sciences University of Auckland Auckland New Zealand
  • Department of Biochemistry School of Biomedical Sciences University of Otago Dunedin New Zealand
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2020-07-02
Volume
155
Issue
1
Pages
62-80
ISSN
  • 0022-3042
  • 1471-4159
Cited by
26
References
20
Language
en
Funders
  • Freemasons New Zealand (3719321)
  • Neurological Foundation of New Zealand (848010)
  • Health Research Council of New Zealand (3627373)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.